News New leader for UK’s molecular biology ‘Nobel Prize factory’ One of the UK’s leading institutes for early biomedical research has appointed Dr Jan Löwe as its new leader.
News Acacia Pharma stock market launch to support nausea products Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange
News Novo Nordisk undeterred after losing out on Ablynx takeover After losing out to Sanofi in its pursuit of Belgian biotech Ablynx earlier this week, Novo Nordisk has put a brave face on the disappointment.
News New Vertex drugs could help 90% of cystic fibrosis patients Vertex soars after news that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time.
News Amazon, Buffet and JPMorgan healthcare plans send US insurer... News that Amazon, Warren Buffett’s Berkshire Hathaway and JP Morgan are to join forces to launch a health plan for their US employees yesterday stopped the whole of healthcare in
News NHS England plans to eliminate hep C by 2025 - with the help... Health chiefs ask pharma to collaborate
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
